The 2-sample problem for failure rates depending on a continuous mark: An application to vaccine efficacy

Biostatistics

Volumn 9, Issue 2, 2008, Pages 263-276

  Gilbert, Peter B ^a   McKeague, Ian W ^b   Sun, Yanqing ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Mailman School of Public Health   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Competing risks; Genetic data; Mark variable; Nonparametric statistics; Proportional hazards; Survival analysis

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; BIOMETRY; CLINICAL TRIAL; COMPUTER SIMULATION; GENETIC POLYMORPHISM; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METHODOLOGY; PROPORTIONAL HAZARDS MODEL; RISK; STATISTICS; SURVIVAL; TREATMENT FAILURE; VACCINATION;

AIDS VACCINES; BIOMETRY; CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; HIV; HIV INFECTIONS; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT FAILURE; VACCINATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 41149170073     PISSN: 14654644     EISSN: 14684357     Source Type: Journal    
DOI: 10.1093/biostatistics/kxm028     Document Type: Article

References (14)

1. ANDERSEN, P. K., BORGAN, O., GILL, R. D. AND KEIDING, N. (1993). Statistical Models Based on Counting Processes. New York: Springer.
2. FLYNN, N. M., FORTHAL, D. N., HARRO, C. D., MAYER, K. H., PARA, M. F. AND THE RGP120 HIV VACCINE STUDY GROUP. (2005). Placebo-controlled trial of a recombinant glycoprotein 120 vaccine to prevent HIV infection. The Journal of Infectious Diseases 191, 654-665.
3. GASSER, T. AND MÜLLER, H.-G. (1979). Kernel estimation of regression functions. In: Gasser, T. and Rosenblatt, M. (editors), Smoothing Techniques for Curve Estimation. Lecture Notes in Mathematics, Volume 757. Berlin: Springer, pp. 23-68.
4. GILBERT, P. B. (2000). Large sample theory of maximum likelihood estimates in semiparametric biased sampling models. Annals of Statistics 28, 151-194.
5. GILBERT, P. B., LELE, S. AND VARDI Y (1999). Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials. Biometrika 86, 27-43.
6. GILBERT, P. B., MCKEAGUE, I. W. AND SUN, Y (2004). Tests for comparing mark-specific hazards and cumulative incidence functions. Lifetime Data Analysis 10, 5-28.
7. GILBERT, P. B., WEI, L. J., KOSOROK, M. R. AND CLEMENS, J. D. (2002). Simultaneous inference on the contrast of two hazard functions with censored observations. Biometrics 58, 773-780.
8. HALLORAN, M. E., HABER, M. J. AND LONGINI, I. M. (1992). Interpretation and estimation of vaccine efficacy under heterogeneity. American Journal of Epidemiology 136, 328-343.
9. HALLORAN, M. E., STRUCHINER, C. J. AND LONGINI, I. M. (1997). Study designs for different efficacy and effectiveness aspects of vaccination. American Journal of Epidemiology 146, 789-803.
10. HUANG, Y AND LOUIS, T. A. (1998). Nonparametric estimation of the joint distribution of survival time and mark variables. Biometrika 85, 785-798.
11. LIN, D. Y., WEI, L. J. AND YING, Z. (1993). Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80, 557-572.
12. PRENTICE, R. L., KALBFLEISCH, J. D., PETERSON, A. V., FLOURNEY, N., FAREWELL, V. T. AND BRESLOW, N. E. (1978). The analysis of failure times in the presence of competing risks. Biometrics 34, 541-554.
13. SUN, Y (2001). Generalized nonparametric test procedures for comparing multiple cause-specific hazard rates. Journal of Nonparametric Statistics 13, 171-207.
14. WYATT, R., KWONG, P. D., DESJARDINS, E., SWEET, R. W., ROBINSON, J., HENDRICKSEN, W. A. AND SODROSKI, J. G. (1998). The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393, 705-711.